Wescott Financial Advisory Group, LLC E Ffector Therapeutics, Inc. Transaction History

Wescott Financial Advisory Group, LLC

  • $763 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$0.35 - $0.67 $3,500 - $6,700
-10,000 Reduced 24.66%
30,556 $10,000
Q4 2022

Feb 06, 2023
SELL
$0.38 - $0.66 $5,700 - $9,900
-15,000 Reduced 27.0%
40,556 $17,000
Q3 2022

Nov 14, 2022
BUY
$0.08 - $1.41 $4,444 - $78,333
55,556 New
55,556 $32,000

Others Institutions Holding EFTR

# of Institutions
6
Shares Held
6.53M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Wescott Financial Advisory Group, LLC Portfolio

Follow Wescott Financial Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wescott Financial Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wescott Financial Advisory Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email